CRISPR Therapeutics AG (NASDAQ:CRSP)

92.79
Delayed Data
As of Oct 23
 +2.63 / +2.92%
Today’s Change
32.30
Today|||52-Week Range
111.90
+52.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues563.0K115.0K328.0K318.0K
 
 
 
 
 
Depreciation And Amortization883.0K945.0K1.0M1.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses49.1M44.4M47.8M54.1M
 
 
 
 
 
Research And Development39.8M28.8M33.8M39.5M
 
 
 
 
 
Total Operating Expenses50.0M45.3M48.8M55.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-49.4M-45.2M-48.4M-55.0M
 
 
 
 
 
Extraordinary Charge-100.0K0.000.000.00
 
 
Pre-Tax Equity Earnings-1.0M0.00-1.0M-1.0M
 
 
 
 
Other Expenses-30.0K-2.1M1.1M2.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-50.6M-47.4M-48.3M-53.6M
 
 
 
 
 
Income Taxes-137.0K-234.0K-85.0K-85.0K
 
 
 
 
 
Net Income-50.7M-47.6M-48.4M-53.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS47.4M51.7M52.1M53.2M
 
 
 
 
 
Shares To Calculate EPS Diluted47.4M51.7M52.1M53.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.07-$0.92-$0.93-$1.01
 
 
 
 
 
EPS Diluted-$1.07-$0.92-$0.93-$1.01